NCT04255602View on ClinicalTrials.gov

A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

2,120

Participants

Timeline

Start Date

February 19, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Acute Coronary SyndromeCoronary Stent Implantation
Interventions
DRUG

Ticagrelor 60mg

Ticagrelor 60mg plus Aspirin 100mg for experimental group

DRUG

Ticagrelor 90mg

Ticagrelor 90mg plus Aspirin 100mg for active comparator group

Trial Locations (8)

200032

NOT_YET_RECRUITING

zhangshan hospital, Fudan University, Shanghai

200050

RECRUITING

shanghai Tongren hospital, Shanghai

201100

NOT_YET_RECRUITING

Minhang hospital, Fudan University, Shanghai

529200

RECRUITING

Taishan people's hospital, Taishan

Unknown

RECRUITING

South East of Shandong hospital, Liaocheng

NOT_YET_RECRUITING

Songjiang hospital, Shanghai jiaotong university, school of medicine, Shanghai

RECRUITING

Ningbo 4th hospital, Xiangshan

NOT_YET_RECRUITING

Yanzhou branch of affiliated hospital of Jining medical university, Jining

All Listed Sponsors
collaborator

Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

Fudan University

OTHER

lead

Shanghai Tong Ren Hospital

OTHER